Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2008
12/03/2008CN100439399C Human antibodies that bind human IL-12 and methods for producing
12/03/2008CN100439398C Human monoclonal antibodies to dendritic cells
12/03/2008CN100439395C Compositions and methods for therapy and diagnosis of ovarian cancer
12/02/2008USRE40596 Rapamycin assay
12/02/2008US7459601 Animal model for use in monitoring aggregation of alpha -synuclein non-amyloid component (NAC) and identifying agent for treatment of nervous system disorders; neuroprotective agents
12/02/2008US7459544 Comprises nucleotide sequences coding b lymphocyte antigens for use as tool in prevention and treatment of cell proliferative disorders; immunotherapy
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459539 Composition for modulating activity of transport protein; for use in tumor diagnosis and treatment; antitumor/anticarcinogenic agents
12/02/2008US7459538 Recombinant tumor specific antibody and use thereof
12/02/2008US7459537 Anti-lymphotoxin-β receptor antibodies as anti-tumor agents
12/02/2008US7459536 HGF-SF monoclonal antibody combinations
12/02/2008US7459533 Interleukin-10 homolog for use as a therapeutic tool in treatment and prevention of inflammatory, autoimmue and cell proliferative disorders
12/02/2008US7459532 Transient receptor potential cation channel for use in identifying modulators for prevention and treatment of cell proliferative and nervous system disorders
12/02/2008US7459528 DNA sequences encoding tumor necrosis factor receptors; recombinant expression vectors
12/02/2008US7459524 Polypeptide of given sequence; use in vaccines
12/02/2008US7459523 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis
12/02/2008US7459440 Ocular tear growth factor-like protein
12/02/2008US7459437 Molecular determinants of myeloma bone disease and uses thereof
12/02/2008US7459427 Reducing glucagon production by administering a corticotrophin releasing factor receptor 2 antagonist, especially a Urocortin III analog; treating high body temperature, appetite dysfunction, congestive heart failure, vascular disease, stress and anxiety.
12/02/2008US7459310 DNA encoding protein of given amino acid sequence; culturing transformant comprising vector; screening for ligands; cancer and reproductive treatment
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459287 Screening agents which modulate formation of FANCD2-containing foci; cell expressing polynucleotide comprising DNA sequence encoding protein
12/02/2008US7459281 Measuring binding of conjugate to monoclonal antibody; determine optimal drug concentrations during chemotherapy and control side effects
12/02/2008US7459275 Sequencing of surface immobilized polymers utilizing microfluorescence detection
12/02/2008US7459172 Drug encapsulation; hollow tubes; drug delivery
12/02/2008US7459158 Can be used to vaccinate a mammal against specific self or non-self antigens
12/02/2008US7459156 Antibodies that mimic actions of neurotrophins
12/02/2008US7459143 Monoclonal antibodies; determination blood coagulation; dissolving clots; administering deimmunized immunointeractive molecules; using planar or computer assisted tomographic nuclear medicine scan to visualize a clot
12/02/2008CA2475116C Polypeptides involved in the expression of resistance to glycopeptides antibiotics
12/02/2008CA2315716C Interactive dental restorative network
12/02/2008CA2267671C Method for manufacturing expanded hematopoietic cells with stem cell factor polypeptide
12/02/2008CA2265484C Tumor homing molecules, conjugates derived therefrom, and methods of using same
12/02/2008CA2241918C Peanut allergens and methods
12/02/2008CA2226400C Human complementarity determining region (cdr) - grafted antibody to ganglioside gm2
12/02/2008CA2172663C Improved reagents for a cannabinoid immunoassay
12/02/2008CA2140538C Monoclonal antibodies that block ligand binding to the cd22 receptor in mature b cells
12/02/2008CA2120527C Helicobacter pylori genes necessary for the regulation and the maturation of urease and their use
12/01/2008CA2590593A1 Mutated hoxb4 proteins with improved stability, and methods of use thereof
11/2008
11/27/2008WO2008144763A2 Antibodies to il-6 and use thereof
11/27/2008WO2008144757A1 Novel rabbit antibody humanization methods and humanized rabbit antibodies
11/27/2008WO2008144753A2 Antibodies to tnf alpha and use thereof
11/27/2008WO2008144720A2 Inhibitors of igf-1r signaling for the treatment of respiratory disorders
11/27/2008WO2008144646A1 Novel primate chitinases and uses therefor
11/27/2008WO2008143936A1 Methods of enhancing adenoviral delivery
11/27/2008WO2008143894A2 Phosphorylated rala
11/27/2008WO2008143797A1 Methods of producing a secreted protein
11/27/2008WO2008143717A2 Methods of determining lethality of pathogens and malignancies involving replikin peak genes
11/27/2008WO2008143708A2 Methods and materials related to anti-amyloid antibodies
11/27/2008WO2008143702A2 Anti-mrp3 antibodies and methods of use
11/27/2008WO2008143697A2 Antibody with protein a selectivity
11/27/2008WO2008143684A1 Methods of generation use of in vivo biotinylated recombinant antibodies
11/27/2008WO2008143665A1 Inhibition of tumor metastasis by anti neuropilin 2 antibodies
11/27/2008WO2008143594A1 Hypoallergenic polypeptides
11/27/2008WO2008143151A1 Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
11/27/2008WO2008142693A2 Regulation of myelination by nectin-like (necl) molecules
11/27/2008WO2008142405A1 Method for predicting the response of a patient to treatment with an anti-tnf alpha antibody
11/27/2008WO2008142165A1 Amino acid sequences directed against growth factor receptors and polypeptides comprising the same for the treatment of diseases and disorders associated with growth factors and their receptors
11/27/2008WO2008142164A2 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
11/27/2008WO2008142157A1 Antibodies useful for therapy and diagnosis of cancer
11/27/2008WO2008142124A1 Recombinant protein production in avian ebx® cells
11/27/2008WO2008141511A1 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF
11/27/2008WO2008141480A1 Human angiostatin interacting and tumor metastasis involving protein variants and uses thereof
11/27/2008WO2008141449A1 Single-domain antibodies and heavy chain antibody against egfr and uses thereof
11/27/2008WO2008141400A1 A novel aetiologic agent of acute gastroenteritis (age), diagnostic methods and therapeutic treatment thereof
11/27/2008WO2008141391A1 Neutralizing antibodies
11/27/2008WO2008124570A8 Methods for inhibiting the binding of endosialin to ligands
11/27/2008WO2008113916A3 Pharmaceutical composition containing antibodies directed against the herv-w envelope
11/27/2008WO2008103701A3 Ovr115 antibody compositions and methods of use
11/27/2008WO2008088582A3 Methods and materials related to trail isoforms
11/27/2008WO2008077945A3 Anti-chemokine (ccl2, ccl3, ccl5, cxcl11, cxcl12) single-domain antibodies
11/27/2008WO2008070135A3 Methods of treating systemic lupus erythematosus
11/27/2008WO2008068359A8 Method for producing antibodies by immunisation with haptens bound to metal oxide particles
11/27/2008WO2008057459A3 Antagonists of pcsk9
11/27/2008WO2008057458A3 Antagonists of pcsk9
11/27/2008WO2008055242A3 Early detection of diabetes
11/27/2008WO2008051505A3 Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
11/27/2008WO2008006087A3 Antibodies to conformationally trapped proteins
11/27/2008WO2007133702A3 Reagents for the detection of protein acetylation signaling pathways
11/27/2008WO2007087453A3 Compositions and methods for treating haematological proliferative disorders
11/27/2008US20080295197 Stimulating root growth; point mutations
11/27/2008US20080293921 HSG (histamine-succinyl-glycine)-binding antibody; binds to a targeted cancer tissue
11/27/2008US20080293625 Diagnosis of Inflammatory Bowel Diseases, More Particularly Ulcerative Colitis
11/27/2008US20080293162 Methods and compositions for diagnosing neoplastic disease
11/27/2008US20080293118 Magnetic fine particles having lower critical solution temperature
11/27/2008US20080293116 Ovary-specific genes and proteins
11/27/2008US20080293106 Method For the Mass Production of Immunoglobulin Fc Region Deleted Initial Methionine Residues
11/27/2008US20080293077 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic and other uses
11/27/2008US20080293043 Method of Detecting Metastisizing Cancer Cells Originating in Stomach Cancer
11/27/2008US20080293036 Monoclonal Antibodies to Hiv-1 and Methods of Using Same
11/27/2008US20080292704 Methods and Compositions Involving Polymeric Immunoglobulin Fusion Proteins
11/27/2008US20080292654 Human Bocavirus and Methods of Diagnosis and Treatment
11/27/2008US20080292647 immunogenic protein in a biodrug, was encoded from an isolated host cell transfected with the recombinant expression vector; anticarcinogenic agent for treating skin cancer; vaccine for prevention and treatment; immunotherapy
11/27/2008US20080292646 Recombinant fusion protein and polynucleotide construct for immunotoxin production
11/27/2008US20080292645 Antibody or Antibody Fragment Coupled with an Immunogenic Agent
11/27/2008US20080292642 Crystalline anti-human IL-12 antibodies
11/27/2008US20080292641 Antigenic GM-CSF peptides and antibodies to GM-CSF
11/27/2008US20080292639 Humanized Anti-Amyloid Antibody
11/27/2008US20080292638 monoclonal antibodies or antigen-binding fragments, that neutralize mature human transforming growth factors, useful for treating cell proliferative disorders in mammals
11/27/2008US20080292636 Chemokine panec-2 polynuleotides, polypeptides, antibodies and methods of making and using them
1 ... 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 ... 1494